CEN BIOTECH INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cen Biotech Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q3 2022.
  • Cen Biotech Inc Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2022 was $8.3M, a 7.79% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $8.3M +$600K +7.79% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $8.3M +$700K +9.21% Jun 30, 2022 10-Q 2022-08-22
Q4 2021 $3.4M $0 0% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $7.7M -$500K -6.1% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 $7.6M +$100K +1.33% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.5M -$3.4M -49.3% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $3.4M -$3.4M -50% Dec 31, 2020 10-Q 2022-05-20
Q3 2020 $8.2M +$1.7M +26.2% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $7.5M +$1.4M +23% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $6.9M -$3.1M -31% Mar 31, 2020 10-Q 2020-06-12
Q4 2019 $6.8M +$1.5M +28.3% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $6.5M -$2.3M -26.1% Sep 30, 2019 10-Q 2019-11-18
Q2 2019 $6.1M -$600K -8.96% Jun 30, 2019 10-Q 2019-08-19
Q1 2019 $10M +$3.7M +58.7% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $5.3M -$600K -10.2% Dec 31, 2018 10-K 2020-04-14
Q3 2018 $8.8M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $6.7M Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $6.3M +$400K +6.78% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 $5.9M +$3.9M +195% Dec 31, 2017 10-K 2019-04-16
Q1 2017 $5.9M Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $2M Dec 31, 2016 10-K 2018-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.